Pear Therapeutics, Inc.

PEAR · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$48,301$169,567$110,900$27,415
Short-Term Investments$10,971$5,004$13,535$77,034
Receivables$6,943$1,794$257$1,008
Inventory$69$0$0$0
Other Curr. Assets$6,675$8,876$1,365$1,521
Total Curr. Assets$72,959$185,241$126,057$106,978
Property Plant & Equip (Net)$14,955$6,255$4,277$680
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$7,215$5,664$2,032$2,034
Total NC Assets$22,170$11,919$6,309$2,714
Other Assets$0$0$0$0
Total Assets$95,129$197,160$132,366$109,692
Liabilities
Payables$3,263$1,806$4,506$2,696
Short-Term Debt$29,431$26,993$26,345$4,444
Tax Payable$0$0$0$0
Deferred Revenue$284$421$267$3,633
Other Curr. Liab.$16,464$17,946$9,568$6,328
Total Curr. Liab.$49,442$47,166$40,686$17,101
LT Debt$8,176$0$0$10,719
Deferred Rev, NC$0$0$0$2,510
Deferred Tax Liab, NC$0$0$0$144,879
Other NC Liab.$6,926$59,560$273,986$526
Total NC Liab.$15,102$59,560$273,986$158,634
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$64,544$106,726$314,672$175,735
Equity
Pref Stock$0$0$0$0
Common Stock$14$14$1$1
Retained Earnings-$323,474-$247,983-$182,841-$69,844
AOCI-$47-$1$0$29
Other Equity$354,092$338,404$534$3,771
Total Equity$30,585$90,434-$182,306-$66,043
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$95,129$197,160$132,366$109,692
Net Debt-$10,694-$142,574-$84,555-$12,252